Free Trial
NASDAQ:NUTX

Nutex Health (NUTX) Stock Price, News & Analysis

Nutex Health logo
$95.66 -1.53 (-1.57%)
Closing price 04:00 PM Eastern
Extended Trading
$95.20 -0.47 (-0.49%)
As of 06:11 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Nutex Health Stock (NASDAQ:NUTX)

Key Stats

Today's Range
$93.00
$99.99
50-Day Range
$80.92
$137.83
52-Week Range
$17.51
$184.27
Volume
153,508 shs
Average Volume
152,691 shs
Market Capitalization
$531.87 million
P/E Ratio
8.05
Dividend Yield
N/A
Price Target
$252.50
Consensus Rating
Buy

Company Overview

Nutex Health Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
41st Percentile Overall Score

NUTX MarketRank™: 

Nutex Health scored higher than 41% of companies evaluated by MarketBeat, and ranked 660th out of 954 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Nutex Health has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.

  • Upside Potential

    Nutex Health has a consensus price target of $252.50, representing about 165.7% upside from its current price of $95.03.

  • Amount of Analyst Coverage

    Nutex Health has only been the subject of 1 research reports in the past 90 days.

  • Read more about Nutex Health's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Nutex Health is 7.99, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 280.44.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Nutex Health is 7.99, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 75.17.

  • Price to Book Value per Share Ratio

    Nutex Health has a P/B Ratio of 2.56. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Nutex Health's valuation and earnings.
  • Percentage of Shares Shorted

    31.64% of the float of Nutex Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Nutex Health has a short interest ratio ("days to cover") of 4.5.
  • Change versus previous month

    Short interest in Nutex Health has recently increased by 25.55%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Nutex Health does not currently pay a dividend.

  • Dividend Growth

    Nutex Health does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    31.64% of the float of Nutex Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Nutex Health has a short interest ratio ("days to cover") of 4.5.
  • Change versus previous month

    Short interest in Nutex Health has recently increased by 25.55%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Nutex Health has a news sentiment score of -0.01. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.94 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 34 news articles for Nutex Health this week, compared to 5 articles on an average week.
  • Search Interest

    Only 6 people have searched for NUTX on MarketBeat in the last 30 days. This is a decrease of -33% compared to the previous 30 days.
  • MarketBeat Follows

    Only 2 people have added Nutex Health to their MarketBeat watchlist in the last 30 days. This is a decrease of -60% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Nutex Health insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    36.92% of the stock of Nutex Health is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 5.32% of the stock of Nutex Health is held by institutions.

  • Read more about Nutex Health's insider trading history.
Receive NUTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nutex Health and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

NUTX Stock News Headlines

Warren Buffett Issues Cryptic Warning on U.S. Dollar
Imagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA or Bitcoin, but by owning a simple index fund. It sounds impossible. Yet it happened – just a short time ago. Now a legendary figure says: "Brace yourselves. It's about to happen here, in America. But fair warning – it could be the worst thing that ever happens to you." This story has received little coverage in the press. But if history repeats, it could bump tens of millions of Americans into a 7-figure net worth practically overnight.tc pixel
Nutex Health (NASDAQ:NUTX) Cut to Hold at Wall Street Zen
See More Headlines

NUTX Stock Analysis - Frequently Asked Questions

Nutex Health's stock was trading at $31.69 at the beginning of 2025. Since then, NUTX stock has increased by 199.9% and is now trading at $95.03.

Nutex Health Inc. (NASDAQ:NUTX) released its quarterly earnings data on Tuesday, May, 13th. The company reported $2.56 EPS for the quarter, beating analysts' consensus estimates of ($0.15) by $2.71. The business earned $211.79 million during the quarter, compared to analysts' expectations of $81.09 million. Nutex Health had a trailing twelve-month return on equity of 42.08% and a net margin of 10.76%.
Read the conference call transcript
.

Shares of Nutex Health reverse split on the morning of Wednesday, July 3rd 2024.The 1-10 reverse split was announced on Wednesday, July 3rd 2024. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, July 3rd 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Top institutional investors of Nutex Health include Topline Capital Management LLC (5.56%), American Century Companies Inc. (1.87%), Marshall Wace LLP (1.70%) and Geode Capital Management LLC (1.42%). Insiders that own company stock include Thomas T Vo, Jon Christian Bates, Joshua Detillio, John J Waters, Pamela W Montgomery and Michael Lee Reed.
View institutional ownership trends
.

Shares of NUTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Nutex Health investors own include Predictive Oncology (POAI), Ford Motor (F), Wells Fargo & Company (WFC), JPMorgan Chase & Co. (JPM), Abbott Laboratories (ABT), Bank of America (BAC) and Cricut (CRCT).

Company Calendar

Last Earnings
5/13/2025
Today
9/15/2025
Next Earnings (Estimated)
9/16/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medical Services
Sub-Industry
Business Services
Current Symbol
NASDAQ:NUTX
CIK
1479681
Employees
1,150
Year Founded
N/A

Price Target and Rating

High Price Target
$300.00
Low Price Target
$205.00
Potential Upside/Downside
+165.5%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
$11.89
Trailing P/E Ratio
8.04
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$52.18 million
Net Margins
10.76%
Pretax Margin
27.66%
Return on Equity
42.08%
Return on Assets
11.80%

Debt

Debt-to-Equity Ratio
1.02
Current Ratio
2.27
Quick Ratio
2.26

Sales & Book Value

Annual Sales
$479.95 million
Price / Sales
1.10
Cash Flow
$12.89 per share
Price / Cash Flow
7.38
Book Value
$37.13 per share
Price / Book
2.56

Miscellaneous

Outstanding Shares
5,560,000
Free Float
3,504,000
Market Cap
$528.81 million
Optionable
Not Optionable
Beta
-0.17
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (NASDAQ:NUTX) was last updated on 9/15/2025 by MarketBeat.com Staff
From Our Partners